Work

Supplementary Table from Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table from Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361891532
Cites:
Cited by:
Related to: 10